Agenus (AGEN) Net Margin (2010 - 2026)

Agenus' (AGEN) quarterly Net Margin came in at 116.11% in Q1 2026, up 22132.0% year-on-year from N/an in Q1 2025, and up 473.55% quarter-over-quarter from 31.08% in Q4 2025.

Agenus (AGEN) Net Margin (2010 - 2026) Analysis & Trends

Agenus' Net Margin history runs 17 years deep, the most recent figure standing at 116.11% for Q1 2026.

  • On a quarterly basis, Net Margin rose 22132.0% year-over-year to 116.11% in Q1 2026; TTM through Mar 2026 was 51.98%, a 24370.0% increase from a year earlier, with the FY2025 full-year figure at 0.09%, up 21973.0% from the prior year.
  • Net Margin advanced to 116.11% in Q1 2026 per AGEN's latest filing, from 31.08% in the prior quarter.
  • Across five years, Net Margin topped out at 211.21% in Q3 2025 and bottomed at 298.26% in Q1 2023.
  • The 5-year median for Net Margin is 186.49% (2022), against an average of 127.65%.
  • Biggest YoY gain for Net Margin was 55458 bps in 2022; the steepest drop was 30891 bps in 2022.
  • Year by year, Net Margin stood at 160.46% in 2022, then plunged by 134 bps to 55.3% in 2023, then plunged by 209 bps to 171.08% in 2024, then soared by 82 bps to 31.08% in 2025, then surged by 474 bps to 116.11% in 2026.
  • Per Business Quant, the three latest AGEN Net Margin figures stand at 116.11% (Q1 2026), 31.08% (Q4 2025), and 211.21% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Agenus 184.05 Mn 177.29 Mn 33.74 Mn 116.11%

Historic Data

Download Data
DateValue
Mar 31, 2026 116.11%
Dec 31, 2025 -31.08%
Sep 30, 2025 211.21%
Jun 30, 2025 -109.02%
Mar 31, 2025 -105.21%
Dec 31, 2024 -171.08%
Sep 30, 2024 -264.57%
Jun 30, 2024 -226.02%
Mar 31, 2024 -221.17%
Dec 31, 2023 -55.30%
Sep 30, 2023 -256.04%
Jun 30, 2023 -273.04%
Mar 31, 2023 -298.26%
Dec 31, 2022 160.46%
Sep 30, 2022 -238.34%
Jun 30, 2022 -222.15%
Mar 31, 2022 -186.49%
Dec 31, 2021 -323.60%
Sep 30, 2021 70.57%
Jun 30, 2021 -776.73%